Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.65% of ...

Intuitive Surgical (NASDAQ:ISRG) shares maintained their Buy rating and a $561.00 price target from BTIG, despite potential ...

Ginkgo Bioworks Holdings Inc (DNA) stock saw a modest uptick, ending the day at $10.83 which represents a slight increase of $0.63 or 6.18% from the prior close of $10.2. The stock opened at $10.31 ...

BTIG analyst Marie Thibault reiterated a Buy rating on Masimo (MASI – Research Report) today and set a price target of $178.00. The company’s ...

Prologis (NYSE:PLD – Get Free Report) had its price objective cut by analysts at BTIG Research from $154.00 to $134.00 in a report released on Friday. The brokerage currently has a “buy” rating on the ...

StockNews.com upgraded shares of FTAI Aviation (NYSE:FTAI – Free Report) to a sell rating in a report released on Tuesday. Several other analysts also recently weighed in on the stock. Citigroup ...

Tuesday, shares of Ideaya Biosciences (NASDAQ:IDYA), trading at $22.18 near its 52-week low of $22.10, drew attention as BTIG analysts maintained their Buy rating and $62.00 price target. According to ...

Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment ...

BTIG raised the firm’s price target on Akebia (AKBA) to $10 from $5 and keeps a Buy rating on the shares. The firm cites the company’s Vafseo ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they could rally this year.

to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical Technology names. BTIG is increasing its estimates for U.S ...

BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating on the shares as part of a broader research note updating the firm ...